VCT Stock Overview
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£17.62|
|52 Week High||UK£25.40|
|52 Week Low||UK£15.85|
|1 Month Change||1.21%|
|3 Month Change||-0.51%|
|1 Year Change||-24.64%|
|3 Year Change||-12.77%|
|5 Year Change||-27.46%|
|Change since IPO||590.98%|
Recent News & Updates
Should You Investigate Victrex plc (LON:VCT) At UK£18.12?
Victrex plc ( LON:VCT ), is not the largest company out there, but it saw a decent share price growth in the teens...
Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Are Investors Undervaluing Victrex plc (LON:VCT) By 38%?
How far off is Victrex plc ( LON:VCT ) from its intrinsic value? Using the most recent financial data, we'll take a...
|VCT||GB Chemicals||GB Market|
Return vs Industry: VCT exceeded the UK Chemicals industry which returned -30.4% over the past year.
Return vs Market: VCT underperformed the UK Market which returned -14.4% over the past year.
|VCT Average Weekly Movement||3.9%|
|Chemicals Industry Average Movement||7.7%|
|Market Average Movement||5.5%|
|10% most volatile stocks in GB Market||10.7%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: VCT is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: VCT's weekly volatility (4%) has been stable over the past year.
About the Company
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts.
Victrex Fundamentals Summary
|VCT fundamental statistics|
Is VCT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VCT income statement (TTM)|
|Cost of Revenue||UK£152.70m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Dec 06, 2022
|Earnings per share (EPS)||0.81|
|Net Profit Margin||22.28%|
How did VCT perform over the long term?See historical performance and comparison
3.4%Current Dividend Yield
Is VCT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VCT?
Other financial metrics that can be useful for relative valuation.
|What is VCT's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does VCT's PE Ratio compare to its peers?
|VCT PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
JMAT Johnson Matthey
CRDA Croda International
Price-To-Earnings vs Peers: VCT is expensive based on its Price-To-Earnings Ratio (21.8x) compared to the peer average (17.9x).
Price to Earnings Ratio vs Industry
How does VCT's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings vs Industry: VCT is expensive based on its Price-To-Earnings Ratio (21.8x) compared to the European Chemicals industry average (11.3x)
Price to Earnings Ratio vs Fair Ratio
What is VCT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||21.8x|
|Fair PE Ratio||14.3x|
Price-To-Earnings vs Fair Ratio: VCT is expensive based on its Price-To-Earnings Ratio (21.8x) compared to the estimated Fair Price-To-Earnings Ratio (14.3x).
Share Price vs Fair Value
What is the Fair Price of VCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VCT (£17.62) is trading below our estimate of fair value (£31.09)
Significantly Below Fair Value: VCT is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
How is Victrex forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VCT's forecast earnings growth (9.7% per year) is above the savings rate (0.9%).
Earnings vs Market: VCT's earnings (9.7% per year) are forecast to grow faster than the UK market (8.6% per year).
High Growth Earnings: VCT's earnings are forecast to grow, but not significantly.
Revenue vs Market: VCT's revenue (4.2% per year) is forecast to grow slower than the UK market (4.4% per year).
High Growth Revenue: VCT's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VCT's Return on Equity is forecast to be low in 3 years time (18.5%).
Discover growth companies
How has Victrex performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VCT has high quality earnings.
Growing Profit Margin: VCT's current net profit margins (22.3%) are higher than last year (20.3%).
Past Earnings Growth Analysis
Earnings Trend: VCT's earnings have declined by 11.1% per year over the past 5 years.
Accelerating Growth: VCT's earnings growth over the past year (30.7%) exceeds its 5-year average (-11.1% per year).
Earnings vs Industry: VCT earnings growth over the past year (30.7%) exceeded the Chemicals industry 14.4%.
Return on Equity
High ROE: VCT's Return on Equity (14.8%) is considered low.
Discover strong past performing companies
How is Victrex's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: VCT's short term assets (£197.2M) exceed its short term liabilities (£57.6M).
Long Term Liabilities: VCT's short term assets (£197.2M) exceed its long term liabilities (£59.9M).
Debt to Equity History and Analysis
Debt Level: VCT has more cash than its total debt.
Reducing Debt: Insufficient data to determine if VCT's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: VCT's debt is well covered by operating cash flow (644.9%).
Interest Coverage: VCT earns more interest than it pays, so coverage of interest payments is not a concern.
Discover healthy companies
What is Victrex current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Victrex Dividend Yield vs Market|
|Market Bottom 25% (GB)||2.1%|
|Market Top 25% (GB)||5.9%|
|Industry Average (Chemicals)||3.0%|
|Analyst forecast in 3 Years (Victrex)||3.6%|
Notable Dividend: VCT's dividend (3.38%) is higher than the bottom 25% of dividend payers in the UK market (2.08%).
High Dividend: VCT's dividend (3.38%) is low compared to the top 25% of dividend payers in the UK market (6.02%).
Stability and Growth of Payments
Stable Dividend: VCT's dividend payments have been volatile in the past 10 years.
Growing Dividend: VCT's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (73.6%), VCT's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (106.7%), VCT's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jakob Sigurdsson (58 yo)
Mr. Jakob O. Sigurdsson, BA, MBA, has been the Chief Executive Officer at Victrex plc since October 1, 2017. He has been Independent Non-Executive Director at Coats Group plc since October 1, 2020. Mr. Sig...
CEO Compensation Analysis
|Jakob Sigurdsson's Compensation vs Victrex Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||UK£2m||UK£558k|
|Jun 30 2021||n/a||n/a|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||n/a||n/a|
|Sep 30 2020||UK£889k||UK£558k|
|Jun 30 2020||n/a||n/a|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||n/a||n/a|
|Sep 30 2019||UK£764k||UK£545k|
|Jun 30 2019||n/a||n/a|
|Mar 31 2019||n/a||n/a|
|Dec 31 2018||n/a||n/a|
|Sep 30 2018||UK£1m||UK£500k|
|Jun 30 2018||n/a||n/a|
|Mar 31 2018||n/a||n/a|
|Dec 31 2017||n/a||n/a|
|Sep 30 2017||UK£510k||UK£42k|
Compensation vs Market: Jakob's total compensation ($USD1.75M) is about average for companies of similar size in the UK market ($USD2.19M).
Compensation vs Earnings: Jakob's compensation has increased by more than 20% in the past year.
Experienced Management: VCT's management team is seasoned and experienced (7.2 years average tenure).
Experienced Board: VCT's board of directors are considered experienced (4.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|12 May 22||BuyUK£49,356||Jakob Sigurdsson||Individual||3,000||UK£16.45|
|21 Feb 22||BuyUK£53,013||Jakob Sigurdsson||Individual||2,800||UK£18.93|
|Owner Type||Number of Shares||Ownership Percentage|
|State or Government||107,484||0.1%|
|Employee Share Scheme||187,496||0.2%|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Victrex plc's employee growth, exchange listings and data sources
- Name: Victrex plc
- Ticker: VCT
- Exchange: LSE
- Founded: 1993
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: UK£1.531b
- Shares outstanding: 86.89m
- Website: https://www.victrexplc.com
Number of Employees
- Victrex plc
- Victrex Technology Centre
- Hillhouse International
- FY5 4QD
- United Kingdom
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|VTXP.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jan 1996|
|VCT||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||GBP||Jan 1996|
|VCTL||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||GBP||Jan 1996|
|1OY||BST (Boerse-Stuttgart)||Yes||Ordinary Shares||DE||EUR||Jan 1996|
|1OY||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jan 1996|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/04 00:00|
|End of Day Share Price||2022/10/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.